You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EORTC

Showing 1 - 25 of 6,213
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Validity of EORTC PATSAT-C33 and EORTC OUT-PATSAT7

Recruiting
  • Cancer
    • Paris, France
    • +1 more
    Aug 2, 2023

    PRO for Fighting FT in Ovarian Cancer

    Not yet recruiting
    • Ovarian Cancer
    • Questionnaires
    • Naples, Italy
      Nation Cancer Institute of Naples, Division of Medical Oncology
    Sep 13, 2023

    Cancer, Quality of Life Trial in Regensburg

    Not yet recruiting
    • Cancer
    • Quality of Life
      • Regensburg, Germany
        Center for Clinical Studies, University Hospital Regensburg
      Jul 28, 2022

      Development ofEORTC Immune Checkpoint Inhibitor-specific Quality

      Recruiting
      • Cancer
      • +2 more
        • Paris, France
          Institut Curie
        Nov 2, 2022

        Quality of Life, Dysphagia Trial in Barcelona (EORTC QLQ-C30, EORTC QLQ-OG25, GIQLI)

        Recruiting
        • Quality of Life
        • Dysphagia
        • EORTC QLQ-C30
        • +4 more
        • Barcelona, Spain
          Hospital Uversitari de Bellvitge
        Mar 27, 2023

        Prostate Cancer, Radiotherapy Side Effect, Bowel Dysfunction Trial (Bowel symptoms & QoL assessment)

        Not yet recruiting
        • Prostate Cancer
        • +3 more
        • Bowel symptoms & QoL assessment
        • (no location specified)
        May 19, 2023

        Nonsmall Cell Lung Cancer Stage III, Unresectable Non-Small Cell Lung Carcinoma Trial in Winston-Salem (drug, other, diagnostic

        Not yet recruiting
        • Nonsmall Cell Lung Cancer Stage III
        • Unresectable Non-Small Cell Lung Carcinoma
        • Winston-Salem, North Carolina
          Wake Forest Baptist Comprehensive Cancer Center
        Jan 12, 2023

        Preoperative Nutritional Status and Postoperative Outcomes in

        Recruiting
        • Colorectal Cancer
        • Nutrition Risk Screening 2002 (NRS-2002)
        • +8 more
        • Ankara, Turkey
        • +1 more
        Aug 29, 2023

        QOL After SURGERY and ADJUVANT Treatment

        Not yet recruiting
        • Carcinoma, Non-Small-Cell Lung
        • Quality of Life
        • Questionnaires
        • Salamanca, Spain
          Hospital Clínico Universitario
        Oct 30, 2023

        Quality of Life of Pancreatic Cancer Patients:Psychometric

        Recruiting
        • Pancreatic Cancer
        • Questionnaire
        • Taipei county, Taiwan
          Taipei Veterans General Hospital
        Dec 19, 2021

        Rectal Cancer, Low Anterior Resection Syndrome Trial in Ghent (LARS score/ EORTC QLQ C30)

        Completed
        • Rectal Cancer
        • Low Anterior Resection Syndrome
        • LARS score/ EORTC QLQ C30
        • Ghent, Oost-Vlaanderen, Belgium
          University hospital Ghent
        Sep 22, 2023

        Prospective Registration Of Patient Data and Quality of Life in

        Recruiting
        • Uveal Melanoma
        • Quality of life questionnaires
        • +3 more
        • Leiden, Zuid-Holland, Netherlands
          Leiden University Medical Center
        May 11, 2022

        Stage III Solid Tumors, Stage IV Solid Tumors Trial (Comprehensive molecular panel test, EORTC QLQ-30)

        Not yet recruiting
        • Stage III Solid Tumors
        • Stage IV Solid Tumors
        • Comprehensive molecular panel test
        • EORTC QLQ-30
        • (no location specified)
        Jan 25, 2023

        Financial Toxicity and Quality of Life in Patients With TGCT

        Recruiting
        • Testicular Neoplasm
        • Comprehensive Score for financial toxicity (COST)
        • +3 more
        • San Antonio, Texas
          Mays Cancer Center
        Mar 30, 2022

        Stage III Solid Tumors, Stage IV Solid Tumors Trial (Comprehensive liquid molecular panel test, EORTC QLQ-30)

        Not yet recruiting
        • Stage III Solid Tumors
        • Stage IV Solid Tumors
        • Comprehensive liquid molecular panel test
        • EORTC QLQ-30
        • (no location specified)
        Jan 30, 2023

        Quantifying Radiation Induced Vaginal Stenosis

        Recruiting
        • Vaginal Stricture
        • Vaginal Stenosis
        • UCSD Vaginal Dilator Questionnaire
        • EORTC Sexual Health Questionnaire
        • La Jolla, California
          UCSD Moores Cancer Center
        Nov 16, 2022

        Quality of Life Trial in Belgium (EORTC QLQ-C30, EORTC QLQ-GI.NET21, Satisfaction survey)

        Recruiting
        • Quality of Life
        • EORTC QLQ-C30
        • +2 more
        • Brasschaat, Antwerp, Belgium
        • +6 more
        Mar 8, 2022

        Multiple Myeloma in West-Occitanie Region "Living WithMyeloma in

        Recruiting
        • Multiple Myeloma
        • quality of life questionnaires (EORTC QLQ-C30 ; EORTC QLQMY20 ; EQ-5D-5L ; Cohen's stress scale)
        • Toulouse, West-Occitanie, France
          IUCT-Oncopole - Toulouse University Hospital
        Mar 1, 2022

        Peritoneal Carcinomatosis Trial in Vandœuvre-lès-Nancy (Blood sample (20 ml) and EORTC QLQC30 survey)

        Recruiting
        • Peritoneal Carcinomatosis
        • Blood sample (20 ml) and EORTC QLQC30 survey
        • Vandœuvre-lès-Nancy, France
          Institut de Cancérologie de Lorraine
        Mar 29, 2022

        Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (drug, other, procedure)

        Active, not recruiting
        • Head and Neck Squamous Cell Carcinoma
        • Saint Louis, Missouri
          Washington University School of Medicine
        Dec 21, 2022

        Cognition, Brain Tumor, Magnetic Resonance Imaging Trial in Gent, Leuven, Wilrijk (behavioral, diagnostic test, other)

        Not yet recruiting
        • Cognition
        • +5 more
        • Neurocognitive tests: WAIS digit span, HVLT-R, COWAT, MOCA, WAIS digit symbol substitution, TMT A&B, Stroop Color Word Test
        • +3 more
        • Gent, Belgium
        • +2 more
        Feb 3, 2023

        Radiotherapy Side Effects Trial (NCI PRO-CTCAE Questionnaire / EORTC QLQ-C30 Questionnaire)

        Not yet recruiting
        • Radiotherapy Side Effects
        • NCI PRO-CTCAE Questionnaire / EORTC QLQ-C30 Questionnaire
        • (no location specified)
        Jun 1, 2022

        Melanoma Trial (pembrolizumab, )

        Active, not recruiting
        Has Results
        • Melanoma
        • pembrolizumab
        • placebo
        • (no location specified)
        Aug 18, 2022

        Breast Cancer Trial in United States (Capecitabine, Neratinib, EORTC QLQ - BR23, EQ-5D-5L, EORTC QLQ-C30)

        Active, not recruiting
        • Breast Cancer
        • Hartford, Connecticut
        • +9 more
        Apr 15, 2022

        EORTC-endorsed, Prospective European Multicenter Imaging Survey

        Enrolling by invitation
        • Metastatic Colorectal Cancer
        • Imaging survey
        • Facilitation
        • Munich, Bavaria, Germany
          Dept. of Radiology, University Hospital, LMU Munich
        Jan 25, 2021